Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125269215 | 12526921 | 5 | F | 20160901 | 20160705 | 20160908 | PER | PHEH2016US016502 | NOVARTIS | 0.00 | M | Y | 0.00000 | 20160908 | CN | COUNTRY NOT SPECIFIED | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125269215 | 12526921 | 1 | PS | GLEEVEC | IMATINIB MESYLATE | 1 | Unknown | 400 MG, UNK | U | F002A, F0028, F0031 | 21588 | 400 | MG | TABLET | |||||
| 125269215 | 12526921 | 2 | C | PRENATAL /00231801/ | VITAMINS | 1 | Unknown | U | 0 | ||||||||||
| 125269215 | 12526921 | 3 | C | BAYER ASPIRIN | ASPIRIN | 1 | Unknown | U | 0 | ||||||||||
| 125269215 | 12526921 | 4 | C | SUPER B COMPLEX /01995301/ | CYANOCOBALAMINDEXPANTHENOLNIACINAMIDEPYRIDOXINE HYDROCHLORIDERIBOFLAVIN 5'-PHOSPHATE SODIUMTHIAMINE HYDROCHLORIDEVITAMIN B COMPLEX | 1 | Unknown | U | 0 | ||||||||||
| 125269215 | 12526921 | 5 | C | SODIUM | SODIUM | 1 | Unknown | U | 0 | ||||||||||
| 125269215 | 12526921 | 6 | C | POTASSIUM | POTASSIUM | 1 | Unknown | U | 0 | ||||||||||
| 125269215 | 12526921 | 7 | C | FOLIC ACID. | FOLIC ACID | 1 | Unknown | U | 0 | ||||||||||
| 125269215 | 12526921 | 8 | C | METOPROLOL SUCCINATE. | METOPROLOL SUCCINATE | 1 | Unknown | U | 0 | EXTENDED RELEASE TABLET | |||||||||
| 125269215 | 12526921 | 9 | C | PRAVASTATIN. | PRAVASTATIN | 1 | Unknown | U | 0 | ||||||||||
| 125269215 | 12526921 | 10 | C | NAPROXEN. | NAPROXEN | 1 | Unknown | U | 0 | ||||||||||
| 125269215 | 12526921 | 11 | C | TRAMADOL. | TRAMADOL | 1 | Unknown | U | 0 | ||||||||||
| 125269215 | 12526921 | 12 | C | TRAZODONE | TRAZODONE HYDROCHLORIDE | 1 | Unknown | U | 0 | ||||||||||
| 125269215 | 12526921 | 13 | C | SILDENAFIL. | SILDENAFIL | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125269215 | 12526921 | 1 | Product used for unknown indication |
| 125269215 | 12526921 | 2 | Product used for unknown indication |
| 125269215 | 12526921 | 3 | Product used for unknown indication |
| 125269215 | 12526921 | 4 | Product used for unknown indication |
| 125269215 | 12526921 | 5 | Product used for unknown indication |
| 125269215 | 12526921 | 6 | Product used for unknown indication |
| 125269215 | 12526921 | 7 | Product used for unknown indication |
| 125269215 | 12526921 | 8 | Product used for unknown indication |
| 125269215 | 12526921 | 9 | Product used for unknown indication |
| 125269215 | 12526921 | 10 | Product used for unknown indication |
| 125269215 | 12526921 | 11 | Product used for unknown indication |
| 125269215 | 12526921 | 12 | Product used for unknown indication |
| 125269215 | 12526921 | 13 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125269215 | 12526921 | Blood disorder | |
| 125269215 | 12526921 | Fatigue | |
| 125269215 | 12526921 | Product quality issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |